BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 30591933)

  • 1. Organoid models of gastrointestinal Neoplasms: Origin, current status and future applications in personalized medicine.
    Pan Y; Zhao S; Cao Z
    Genes Dis; 2018 Dec; 5(4):323-330. PubMed ID: 30591933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organoids as an in vitro model of human development and disease.
    Fatehullah A; Tan SH; Barker N
    Nat Cell Biol; 2016 Mar; 18(3):246-54. PubMed ID: 26911908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomaterials for intestinal organoid technology and personalized disease modeling.
    Hirota A; AlMusawi S; Nateri AS; Ordóñez-Morán P; Imajo M
    Acta Biomater; 2021 Sep; 132():272-287. PubMed ID: 34023456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organoid based personalized medicine: from bench to bedside.
    Li Y; Tang P; Cai S; Peng J; Hua G
    Cell Regen; 2020 Nov; 9(1):21. PubMed ID: 33135109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organoid technology and applications in cancer research.
    Xu H; Lyu X; Yi M; Zhao W; Song Y; Wu K
    J Hematol Oncol; 2018 Sep; 11(1):116. PubMed ID: 30219074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organoid factory: The recent role of the human induced pluripotent stem cells (hiPSCs) in precision medicine.
    Novelli G; Spitalieri P; Murdocca M; Centanini E; Sangiuolo F
    Front Cell Dev Biol; 2022; 10():1059579. PubMed ID: 36699015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor organoids: synergistic applications, current challenges, and future prospects in cancer therapy.
    Qu J; Kalyani FS; Liu L; Cheng T; Chen L
    Cancer Commun (Lond); 2021 Dec; 41(12):1331-1353. PubMed ID: 34713636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt Signaling in 3D: Recent Advances in the Applications of Intestinal Organoids.
    Merenda A; Fenderico N; Maurice MM
    Trends Cell Biol; 2020 Jan; 30(1):60-73. PubMed ID: 31718893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor organoids for cancer research and personalized medicine.
    Yang H; Wang Y; Wang P; Zhang N; Wang P
    Cancer Biol Med; 2021 Sep; 19(3):319-32. PubMed ID: 34520134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revolutionizing digestive system tumor organoids research: Exploring the potential of tumor organoids.
    Xiu Z; Yang Q; Xie F; Han F; He W; Liao W
    J Tissue Eng; 2024; 15():20417314241255470. PubMed ID: 38808253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-Derived Organoids in Precision Medicine: Drug Screening, Organoid-on-a-Chip and Living Organoid Biobank.
    Zhou Z; Cong L; Cong X
    Front Oncol; 2021; 11():762184. PubMed ID: 35036354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer modeling meets human organoid technology.
    Tuveson D; Clevers H
    Science; 2019 Jun; 364(6444):952-955. PubMed ID: 31171691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances and Applications of Cancer Organoids in Drug Screening and Personalized Medicine.
    Yang Y; Kong Y; Cui J; Hou Y; Gu Z; Ma C
    Stem Cell Rev Rep; 2024 Mar; ():. PubMed ID: 38532032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organoid-based personalized medicine: from tumor outcome prediction to autologous transplantation.
    Soto-Gamez A; Gunawan JP; Barazzuol L; Pringle S; Coppes RP
    Stem Cells; 2024 Jun; 42(6):499-508. PubMed ID: 38525972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of organoids for personalized medicine.
    Perkhofer L; Frappart PO; Müller M; Kleger A
    Per Med; 2018 Nov; 15(6):461-465. PubMed ID: 30418092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential of organoids in urological cancer research.
    Wang S; Gao D; Chen Y
    Nat Rev Urol; 2017 Jul; 14(7):401-414. PubMed ID: 28534535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrointestinal cancer organoids-applications in basic and translational cancer research.
    Seidlitz T; Stange DE
    Exp Mol Med; 2021 Oct; 53(10):1459-1470. PubMed ID: 34663939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Central Role of Wnt Signaling and Organoid Technology in Personalizing Anticancer Therapy.
    Vincan E; Schwab RHM; Flanagan DJ; Moselen JM; Tran BM; Barker N; Phesse TJ
    Prog Mol Biol Transl Sci; 2018 Jan; 153():299-319. PubMed ID: 29389521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organoids: The current status and biomedical applications.
    Yang S; Hu H; Kung H; Zou R; Dai Y; Hu Y; Wang T; Lv T; Yu J; Li F
    MedComm (2020); 2023 Jun; 4(3):e274. PubMed ID: 37215622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease Modeling in Stem Cell-Derived 3D Organoid Systems.
    Dutta D; Heo I; Clevers H
    Trends Mol Med; 2017 May; 23(5):393-410. PubMed ID: 28341301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.